“The departure of Scott Gottlieb from the U.S. Food and Drug Administration on Tuesday is a potential blow to Silicon Valley.
In his two years as commissioner of the FDA, Gottlieb, a doctor and former venture capitalist, gained a reputation as a proponent of health-care innovation, including pharmaceutical companies bringing new drugs to market.
He helped to establish a digital health software program called Pre-Cert to provide a way for tech companies like Apple and Samsung to get quicker approval for low-risk health products. Last September, Apple received clearance to market an electrocardiogram app and sensor on its Apple Watch, the company’s biggest move into the health-care market.
Gottlieb issued a statement at the time to encourage Apple and other tech companies to push into health care, especially if they could help consumers engage more proactively with their health.
“Scott did a lot culturally to make the agency easier to work with,” said Bob Kocher, a partner at venture capital firm Venrock, investing in health-technology. “I think he’ll be missed by many in the tech industry, including the start-ups.”’
Last time on Zeihan on we chatted about the misalignment between American weapons systems and European needs. So, what does the future of Europe’s military…
Oil prices will surge above $100 a barrel if Iran blocks the world’s most important crude shipping route in retaliation for America bombing its nuclear…
President Donald Trump was swept into office last November with a promise to lower prices for Americans who had suffered under 40-year-high inflation under President…